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Kentucky, Lexington, KentuckyABSTRACT Cardiac troponin (cTn) is a key molecule in the regulation of human cardiac muscle contraction. The N-terminal
cardiac-specific peptide of the inhibitory subunit of troponin, cTnI (cTnI1-39), is a target for phosphorylation by protein kinase A
(PKA) during b-adrenergic stimulation. We recently presented evidence indicating that this peptide interacts with the inhibitory
peptide (cTnl137–147) when S23 and S24 are phosphorylated. The inhibitory peptide is also the target of the point mutation cTnI-
R145G, which is associated with hypertrophic cardiomyopathy (HCM), a disease associated with sudden death in apparently
healthy young adults. It has been shown that both phosphorylation and this mutation alter the cTnC-cTnI (C-I) interaction, which
plays a crucial role in modulating contractile activation. However, little is known about the molecular-level events underlying
this modulation. Here, we computationally investigated the effects of the cTnI-R145G mutation on the dynamics of cTn,
cTnC Ca2þ handling, and the C-I interaction. Comparisons were made with the cTnI-R145G/S23D/S24D phosphomimic
mutation, which has been used both experimentally and computationally to study the cTnI N-terminal specific effects of PKA
phosphorylation. Additional comparisons between the phosphomimic mutations and the real phosphorylations were made.
For this purpose, we ran triplicate 150 ns molecular dynamics simulations of cTnI-R145G Ca2þ-bound cTnC1-161-cTnI1-172-
cTnT236-285, cTnI-R145G/S23D/S24D Ca
2þ-bound cTnC1-161-cTnI1-172-cTnT236-285, and cTnI-R145G/PS23/PS24 Ca
2þ-bound
cTnC1-161-cTnI1-172-cTnT236-285, respectively. We found that the cTnI-R145G mutation did not impact the overall dynamics of
cTn, but stabilized crucial Ca2þ-coordinating interactions. However, the phosphomimic mutations increased overall cTn fluctu-
ations and destabilized Ca2þ coordination. Interestingly, cTnI-R145G blunted the intrasubunit interactions between the cTnI
N-terminal extension and the cTnI inhibitory peptide, which have been suggested to play a crucial role in modulating troponin
function during b-adrenergic stimulation. These findings offer a molecular-level explanation for how the HCM mutation cTnI-
R145G reduces the modulation of cTn by phosphorylation of S23/S24 during b-adrenergic stimulation.INTRODUCTIONDuring cardiac muscle contraction, the interactions between
actin and myosin are regulated by Ca2þ binding to troponin
(cTn). Ca2þ binding initiates a chain of events involving
structural and dynamic changes in troponin, tropomyosin,
actin, and myosin, which promote cell contraction (1).
The cTn protein complex consists of three subunits:
troponin C (cTnC, Ca2þ-binding subunit), troponin I
(cTnI, inhibitory subunit), and troponin T (cTnT, tropomy-
osin-binding subunit) (2). Ca2þ binding to cTnC site II
results in an alteration of the dynamics of the molecule,
leading to a more frequent and more pronounced exposure
of a hydrophobic patch on the N-terminal cTnC (NcTnC)
surface between helices A and B (3). This in turn results
in a greater association of the switch peptide of cTnI with
the hydrophobic patch of cTnC, and a subsequent decrease
in the association of cTnI with tropomyosin and actin. As aSubmitted July 29, 2014, and accepted for publication November 21, 2014.
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0006-3495/15/01/0395/13 $2.00result, tropomyosin mobility is increased and sites on actin
are exposed for myosin binding (1,4,5).
The C-I interaction is critical for contractile modulation
on a systolic beat-to-beat basis. During b-adrenergic stimu-
lation, cTnI is phosphorylated by protein kinase A (PKA)
at the N-terminal extension residues Ser-23 and Ser-24
(6–8). Phosphorylation at these sites reduces Ca2þ binding
to cTn, the C-I interaction, and the Ca2þ sensitivity
(pCa50) of force production (7–10). The cTnI N-terminal
extension (NcTnI) interacts with NcTnC, which suggests
that these C-I phosphorylation sites may be important in
modulating C-I interactions.
Several mutations in cTnI have been associated with
cardiomyopathies. In 1997, Kimura and co-workers (11)
first reported that the R145G mutation in cTnI is associ-
ated with hypertrophic cardiomyopathy (HCM), the most
common cause of sudden cardiac death in apparently
healthy young people. Arg-145 (R145) is located in the
inhibitory peptide of cTnI and thus could alter the C-I
interaction and have significant effects on the function ofhttp://dx.doi.org/10.1016/j.bpj.2014.11.3461
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tein biochemical experiments have focused on analyzing
the functional effects of the cTnI-R145G mutation. Initial
studies reported that cTnI-R145G reduces the Ca2þ sensi-
tivity of ATPase activity (12–14). Subsequent studies es-
tablished that cTnI-R145G increases Ca2þ binding to
cTn but has little effect on the exposure of the hydropho-
bic patch in NcTnC (15,16). However, it remains elusive
how cTnI-R145G affects the C-I interaction or the struc-
ture of cTn when Ser-23 and Ser-24 are phosphorylated
by PKA.
We recently investigated the effects of phosphorylation
at NcTnI residues Ser-23 and Ser-24 on C-I interactions
and the structure of wild-type (WT) cTn using protein
biochemical and computational approaches (9,17). We
also previously reported that the reduction of the C-I inter-
action resulting from Ser-23 and Ser-24 phosphorylation is
blunted by cTnI-R145G (18). Based on previous studies
(17), we speculated that cTnI-R145G interferes with the in-
trasubunit cTnI inhibitory peptide interaction with NcTnI
to limit or abrogate the effect of PKA phosphorylation.
Here, to test this hypothesis, we investigated the effects
of cTnI-R145G with and without PKA phosphorylation
of cTnI-S23/S24 on cTn structure and C-I interaction using
molecular dynamics (MD) simulations. Previous studies
have demonstrated that mutation of Ser-23 and Ser-24 to
aspartic acid (S23D/S24D) results in the same changes in
contractile properties of myofibrils (and trabeculae) and
troponin function (in solution) as does PKA treatment of
troponin (19–25). In addition, the use of these bis-phospho-
mimics allows one to investigate the specific role of cTnI
S23/24 phosphorylation in cardiac muscle contraction, as
titin and myosin binding protein C (cMyBP-C) are also
phosphorylated by PKA during b-adrenergic stimulation
(6,26). Thus, for this study, there are good reasons to
believe that phosphomimic mutations recapitulate the ef-
fect of phosphorylation. To investigate this, we ran tripli-
cate simulations of the core cTn complex (including
residues cTnC 1–161, cTnI 1–172, and cTnT 236–285) in
the cTnI-R145G state and in the cTnI-R145G/S23D/
S24D state to mimic phosphorylation. Additionally, we
performed triplicate simulations of the core cTn complex
in the true phosphorylated state (cTnI-R145G/PS23/PS24)
to compare its effects with those of the phosphomimic
mutations. We found that cTnI-R145G stabilized crucial
Ca2þ-coordinating interactions, but did not impact the
overall dynamics of cTn. However, cTnI-R145G/S23D/
S24D destabilized Ca2þ coordination and increased overall
cTn fluctuations. All of the results obtained with cTnI-
R145G/S23D/S24D were corroborated using the cTnI-
R145G/PS23/PS24 phosphorylated system. Interestingly,
cTnI-R145G also altered the intrasubunit cTnI inhibitory
peptide interaction with NcTnI in a way that blunted the
ability of S23/S24 phosphorylation to cause a repositioning
of the N-terminal extension. These results suggest a struc-Biophysical Journal 108(2) 395–407tural basis for the blunting of PKA effects on the C-I inter-
action by cTnI-R145G.MATERIALS AND METHODS
Troponin model building
We used the crystal structure of the core domain of human cTn in the Ca2þ-
saturated form (Protein Data Bank (PDB) ID 1J1E (27) as the basis for
generating the troponin complex without the cTnI N-terminal domain. To
obtain as complete a starting model as possible, we computationally rebuilt
crucial residues missing in the crystal structure domains D, E, and F using
physical principles and information from the PDB. Prime (28,29) was used
for the cTnC modeling. Specifically, the cTnC missing residues 49 and 50
were built in and residues 35 and 84, which were mutated in the crystal
structure, were modeled back to their WT state. Both the cTnI and cTnT
domains had larger fragments of missing residues in the crystal structure.
Therefore, we used Rosetta (30,31) to model these loop regions de novo,
including the cTnI inhibitory peptide (residues 137–147) and the cTnI C-
terminus (residues 192–210). The cTnI N-terminus (residues 1–39) was
modeled based on the NMR structure provided by Howarth et al., as
described in detail in Cheng et al. (17). The cTnT C-terminus (residues
277–288) was also added to the model. The cTnT N-terminus (residues
1–201) was not modeled, because it associates with tropomyosin (32)
and does not contribute to the globular portion of cTn. The final WT cTn
model contained residues cTnC 1–161, cTnI 1–210, and cTnT 202–288.System preparation
For the simulations,we prepared three different systemsof human cTn: cTnI-
R145G Ca2þ-bound cTnC1-161-cTnI1-172-cTnT236-285, cTnI-R145G/S23D/
S24D Ca2þ-bound cTnC1-161-cTnI1-172-cTnT236-285, and cTnI-R145G/
PS23/PS24 Ca2þ-bound cTnC1-161-cTnI1-172-cTnT236-285. The included
residues were chosen to create as compact a simulation system as possible
while maintaining all crucial interacting residues. Truncations were based
in loop regions to fully preserve the integrity of the troponin secondary struc-
ture elements. Mutations were performed using the Mutate Residue module
in VMD (33). The phosphorylations were modeled using the SP2 phospho-
serine patch in VMD’s psfgen. VMD was then used to add a TIP3P water
box with a 14 A˚ padding. Kþ and Cl ions were added to neutralize the
system and obtain a 150 mM ionic strength. The fully solvated systems
contained 102,198 (cTnI-R145G Ca2þ-bound cTnC1-161-cTnI1-172-
cTnT236-285), 112,756 (cTnI-R145G/S23D/S24D Ca
2þ-bound cTnC1-161-
cTnI1-172-cTnT236-285), and 112,750 (cTnI-R145G/PS23/PS24 Ca
2þ-bound
cTnC1-161-cTnI1-172-cTnT236-285) atoms, respectively. The CHARMM27
force field (34) was used for the simulations. Two stages of minimization
were performed using NAMD 2.9 (35): 10,000 steps of minimization of
solvent and ions (the protein was restrained using a force constant of
500 kcal/mol/A˚2) followed by a 10,000 step minimization of the entire sys-
temwithout any restraints. A short initial 380 psMD simulationwith consec-
utively weaker restraints (10–0.1 kcal/mol/A˚2) on the protein residues was
used to heat up the system to a temperature of 300 K. The equilibration
was finished by a short 20 ps NPT simulation without any restraints.MD simulations
All simulations were performed under the NPT ensemble at 300 K using
NAMD 2.9 (35) and the CHARMM27 force field (34). Periodic boundary
conditions were used along with a nonbonded interaction cutoff of 12 A˚.
Bonds involving hydrogen atoms were constrained using the SHAKE algo-
rithm (36), allowing for a time step of 2 fs. Structures were saved every 2 ps.
Triplicate 150 ns MD simulations (three independent 150 ns simulations)
were performed on all systems, and each simulation of the same system
started from different conformations of the cTnI N-terminal extension.
Troponin HCM Mutation Simulations 397Contact analysis
The residue-residue contacts between cTnC and key regions of cTnI (N-ter-
minus, inhibitory peptide, and switch peptide regions), as well as intrasubu-
nit contacts between the cTnI N-terminus and inhibitory peptide, were
monitored over the course of all simulations. Contacts between NcTnC-
NcTnI, the NcTnC-switch peptide of cTnI, and the cTnC-inhibitory peptide
of cTnI were monitored. The intrasubunit interaction between the N-termi-
nus and the inhibitory peptide region of cTnI were also recorded. Contacts
between two residues were defined as previously described by Wang et al.
(37), with a carbon-carbon distance of%5.4 A˚ and a distance between any
other noncarbon atoms of%4.6 A˚ being defined as a contact. For each res-
idue contact pair, the fraction of the simulation time in which these residues
were in contact was calculated for the two simulation systems.Calcium coordination
To monitor the stability of the coordination between the calcium ion and its
cTnC site II binding residues, we recorded the time evolution of the
following distances: Ca2þ-Asp-65 OD2, Ca2þ-Asp-67 OD2, Ca2þ-Ser-69
OG, Ca2þ-Thr-71 OG1, Ca2þ-Asp-73 OD2, and Ca2þ-Glu-76 OE2. These
atoms correspond to the atoms that Ca2þ coordinates within the crystal
structure. Since the Ca2þ coordination atoms within a residue occasionally
switched during the course of the simulations, we also recorded distances
between the following possible alternate coordinating atoms: Ca2þ-Asp-
65 OD1, Ca2þ-Asp-67 OD1, Ca2þ-Asp-73 OD1, and Ca2þ-Glu-76 OE1.
Residues Ser-69 and Thr-71 do not have possible alternative coordinating
atoms. Distances in the WT Ca2þ-bound cTnC1-161-cTnI1-172-cTnT236-285
(17), cTnI-R145G Ca2þ-bound cTnC1-161-cTnI1-172-cTnT236-285, and
cTnI-R145G/S23D/S24D Ca2þ-bound cTnC1-161-cTnI1-172-cTnT236-285
systems were measured every 2 ps. For the sake of analysis, the minimum
distances between Ca2þ and the coordinating atom on each residue were
plotted.FIGURE 1 Static snapshot of the initial structures of the cTn complex
built up based on the PDB 1J1E crystal structure and Howarth et al.’s
NMR structure including the N-terminal extension. cTnC (residues 1–
161) is shown in blue, cTnI (residues 1–171) is in red, and cTnT (residues
236–285) is in orange. The mutational site cTnI-R145 and the two PKA
phosphorylation sites (cTnI-S23/S24) are shown in stick representation.Molecular mechanics/generalized Born surface
area analysis
Molecular mechanics/generalized Born surface area (MM/GBSA) (38)
analysis was used to score cTnI/cTnC binding interactions. The free energy
of binding for the MM/GBSA method is defined as
G ¼ Etot  T S; (1)
where G, Etot, and S are the free energy, total enthalpy, and total entropy,
respectively, and T is the system temperature. In this study, we assumed
that the solute contributions to the entropy were comparable among the
cTnI mutants; thus, we estimated the free energy as
G ¼ Gsolvation þ EVDW þ EINT; (2)
where Gsolvation is the solvation free energy, EVDW is the van der Waals en-
ergetic contribution, while EINT corresponds to internal energies arising
from bonds, angles and dihedrals at 0 K. These terms were evaluated using
the NAMD simulation engine (35) and the CHARMM 27 force field (34),
using the parameters defined above, as well as the gbis keyword for the GB
calculation at an ionic strength of 0.15 M. MM/GBSA was applied to
snapshots recorded at 1 ns intervals from each WT, cTnI-R145G, and
cTnI-R145G/S23D/S24D protein simulation. The binding score, DGBinding,
was estimated by
DGBinding ¼ GTnC=TnI  GTnI  GTnC; (3)
where GTnC/TnI is the energy of the TnC/TnI complex, and GTnI and GTnC
correspond to the energies of the isolated cTnI and cTnC components,respectively. The solvation free energy was computed as the sum of electro-
static and nonpolar contributions (39)
Gsolvation ¼ Gelectrostatic þ Gnonpolar: (4)
To estimate Gelectrostatic, we utilized the GB approximation to the Poisson-
Boltzmann equation, the latter of which quantifies the electrostatic contri-
bution of fixed charges within a solute immersed in an electrolyte solution
(40). The NAMD GB implementation (41) is based on an approximation
for the Born radii proposed originally by Onufriev et al. (42) for numerical
stability. The authors reported agreement between GB and PB within
2–5 kcal/mol for two model protein systems, which we expected was
reasonably accurate for our estimates. The nonpolar term, Gnonpolar, was
calculated in NAMD as a function of the solvent-accessible surface area
(SASA) (43) using
Gnonpolar ¼ SASA$g; (5)
where the SASA was computed via the LCPO method (44) and g ¼
0.0072 kcal/mol/ A˚2 (45) in accordance with related studies on protein-pro-
tein complexes (46).RESULTS AND DISCUSSION
cTnI-R145G has little impact on fluctuations of the
cTn structure
The WT cTn model on which all of the simulations were
based is shown in Fig. 1, with the side chains of cTnI res-
idues S23, S24, and R145 highlighted to identify their po-
sitions. cTnI-R145G and cTnI-R145G/S23D/S24D mutant
systems were generated by introducing the corresponding
mutations into this model. The cTnI-R145G/PS23/PS24
system was generated by introducing the cTnI-R145G
and replacing cTnI-S23 and cTnI-S24 with phosphoserine
residues. Fig. S1 in the Supporting Material shows the
root mean-square deviation (RMSD) versus time plots
for the cTnI-R145G, cTnI-R145G/S23D/S24D, and cTnI-
R145G/PS23/PS24 cTn simulations. All systems reached
an equilibrated state within the simulation time ofBiophysical Journal 108(2) 395–407
398 Lindert et al.150 ns. Our first goal was to assess the effect of cTnI-
R145G on the dynamics of the cTn protein complex. To
compare the dynamics of WT versus cTnI-R145G cTn,
we performed triplicate MD simulations and calculated
the average root mean-square fluctuation (RMSF, 5 SD)
values for all residues. Fig. 2 shows the RMSF of the
cTnC and cTnI subunits for the WT and the cTnI-R145G
system. Interestingly, the fluctuations in the cTnI-R145G
mutant system were comparable to those in the WT system
throughout most of the protein structure (average RMSFs
of 2.8 A˚ and 2.9 A˚, respectively). The only pronounced dif-
ference was seen in the C-terminal domain of cTnC (cTnCFIGURE 2 (A) Comparison of RMSF values of the simulations of WT
(green) and cTnI-R145 (blue) troponin. Shaded boxes indicate important
regions in the protein: the cTnC (inactive) calcium binding site I (green),
the cTnC calcium binding site II (blue), the cTnI inhibitory peptide (yel-
low), and the cTnI switch peptide (red). Uncertainties in RMSF values
were determined by running three independent 150 ns MD simulations
and are given as error bars on the plots. (B and C) Ribbon representations
of the conformations assumed by the troponin molecule during (B) the
WT simulation and (C) the cTnI-R145 mutation simulation. cTnC is shown
in blue, cTnI is in red, and cTnT is in gold. Molecular simulation snapshots
recorded every 20 ns are shown.
Biophysical Journal 108(2) 395–407residues 120–130), the loop connecting the two C-terminal
cTnC EF-hand motifs (which interacts with the cTnI I-T
arm), although a small difference may also exist in the
linker region connecting the N- and C-terminal lobes of
cTnC (cTnC residues 80–100). Most of the other regions
did not exhibit changes larger than the standard deviations
(SDs). The largest fluctuations were observed in the NcTnI
region, underscoring its highly flexible nature. The first 20
cTnI residues were the most flexible, and cTnI20–40 showed
a lower degree of flexibility—a trend that was also
observed in a recent NMR study by Hwang et al. (47).
With fluctuations this large, it is appropriate to refer to a
range of conformations for NcTnI rather than an actual sin-
gle structural conformation. The helical bundle known as
the IT arm (cTnI residues 42–80 and 100–137) comprised
the most stable residues in the cTnI subunits, reflecting
their structural rather than regulatory function. Fig. 2 A
also highlights regions of cTn that play an important part
in either Ca2þ binding (cTnC site I and cTnC site II) or
the C-I interaction. In contrast to previous studies on WT
and phosphomimic WT cTn (or cTnI-S23D/S24D cTn)
(17), we found that the fluctuations in all of these regions
were not influenced by cTnI-R145G. In summary, cTnI-
R145G had little impact on the dynamics of the troponin
complex. This can also be seen in Fig. 2, B and C, where
eight 20 ns incremental simulation snapshots for the WT
and cTnI-R145G mutation simulations are superimposed.
These findings suggest that the predominant mechanism
of enhanced Ca2þ binding and C-I interaction by cTnI-
R145G is not the overall structural fluctuations, at least
on the timescale accessible to our MD simulations. Our
full-atom cTn model is a great complement to the thin-fila-
ment model proposed by Manning et al. (32,48). The cTn
model is a good tool for examining detailed molecular
interactions and obtaining measures of rapid kinetic dy-
namics, whereas the cTn-Tm thin-filament model provides
an excellent picture of the long-range consequences of
local altered structure.Phosphomimic mutations and phosphorylation of
S23 and S24 in cTnI-R145G result in increased
fluctuations throughout the cTn structure
Next, we investigated the influence of PKA phosphoryla-
tion on cTn containing cTnI-R145G. For this purpose, we
performed simulations with simultaneous phosphomimic
mutations S23D and S24D and cTnI-R145G in the troponin
structure. Fig. 3 shows the RMSF of the cTnC and cTnI
subunits for the cTnI-R145G and cTnI-R145G/S23D/
S24D system. The fluctuations in the cTnI-R145G/S23D/
S24D mutant system (average RMSF 3.2 A˚) were
increased with respect to the cTnI-R145G system (average
RMSF 2.8 A˚), akin to what we previously reported for WT
and cTnI-S23D/S24D simulations (17). This increased fluc-
tuation may precipitate the increased fluctuations seen in
FIGURE 3 (A) Comparison of RMSF values of the simulations of cTnI-
R145 (blue) and cTnI-R145G/S23D/S24D (red) troponin. Shaded boxes
indicate important regions in the protein: the cTnC (inactive) calcium bind-
ing site I (green), the cTnC calcium binding site II (blue), the cTnI inhibi-
tory peptide (yellow), and the cTnI switch peptide (red). Uncertainties in
RMSF values were determined by running three independent simulations
and are given as error bars on the plots. (B and C) Ribbon representations
of the conformations assumed by the troponin molecule during (B) the
cTnI-R145 mutation simulation and (C) the cTnI-R145G/S23D/S24D
simulation. cTnC is shown in blue, cTnI is in red, and cTnT is in gold.
Molecular simulation snapshots recorded every 20 ns are shown.
Troponin HCM Mutation Simulations 399NcTnC (Fig. 3 A, top, residues 1–89). Interestingly, there
were increased dynamics in the entire structure of NcTnC,
suggesting that NcTnI mobility can have a profound influ-
ence on NcTnC structure. The average RMSF for the cTnC
site I increased from 2.6 A˚ in the cTnI-R145G system to
3.6 A˚ in the cTnI-R145G/S23D/S24D system, an increase
beyond the SD of the triplicate simulations. The cTnC
site II had an RMSF of 2.8 A˚ in the cTnI-R145G system,
compared with 3.5 A˚ in the cTnI-R145G/S23D/S24D sys-
tem. The increased RMSF of site II may be related to a
destabilization of Ca2þ in the site II binding pocket ofcTnC, leading to the increase in Ca2þ dissociation rate
that has been reported for cTn following phosphorylation
by PKA (16,49). No significant change in fluctuations
was observed in the inhibitory peptide or the switch pep-
tide of cTnI, suggesting that their interaction with NcTnC
is not affected. The significance of this is discussed further
below. Fig. 3 C shows snapshots of the cTnI-R145G/S23D/
S24D system simulations. The increased cTnC (blue) flex-
ibility for the cTnI-R145G/S23D/S24D system compared
with cTnI-R145G (Fig. 3 B) is demonstrated by the cTn
snapshots. The largest change in dynamical behavior be-
tween the two systems occurred in cTnI residues 20–30
(not visible in the snapshot structures), where a statistically
significant increase in local residue fluctuations was
observed. The Ser (S) to Asp (D) mutations broke, stabiliz-
ing interactions in the region (shown in detail further
below). In the cTnI-R145G system (with no phosphomimic
mutations), this region was the most stable part of NcTnI.
Upon introduction of phosphomimic mutations, RMSF
values as high as 9–10 A˚ were observed (compared with
4–5 A˚ for the cTnI-R145G system), suggesting a large in-
crease in the mobility of NcTnI. Simulating the actual
phosphorylated cTn system allowed us to compare the ef-
fects of phosphomimic mutations with those due to the
presence of real phosphoserine residues. To that end, we
performed simulations with phosphoserine substitutions at
residues cTnI-S23 (cTnI-PS23) and cTnI-S24 (cTnI-
PS24) and the cTnI-R145G mutation in the troponin
structure. Fig. S2 shows the RMSF of the cTnC and cTnI
subunits for the cTnI-R145G/S23D/S24D and cTnI-
R145G/PS23/PS24 systems. The overall fluctuations in
both systems are virtually indistinguishable, supporting
the use of phosphomimic mutations instead of phosphoser-
ine residues. A noticeable difference can be found within
NcTnI; however, even there, the two systems agree within
the error bars.MM/GBSA assessment of cTnC/cTnI binding
interactions
MM/GBSA (38) analysis was used to qualitatively estimate
the binding affinity of the cTnI switch peptide to NcTnC.
Although methods such as thermodynamic integration can
provide binding free-energy estimates that are in compara-
tively better agreement with experiments, they do so at a
computational cost that is intractable for large systems,
such as the cTn used in this study. MM/GBSA estimates
the internal energy of a solute using an all-atom, explicit
molecular force field while treating all solute/solvent inter-
actions implicitly through the GB level of solvation theory
(38). MM/GBSA has shown promise for rank-ordering pro-
tein-protein binding free energies (39,50), as well as cTnC/
cTnI binding (51), although quantitative agreement is still
lacking (52). Therefore, we consider the MM/GBSA scores
here as scores to indicate their predictive power in rankingBiophysical Journal 108(2) 395–407
400 Lindert et al.ligands, as opposed to providing quantitative agreement
with experimentally observed affinities.
In Fig. 4, we report the means and confidence intervals
of the MM/GBSA binding scores for the cTnC/cTnI inter-
face (cTnC residues 1–90, cTnI residues 138–171) for the
WT, cTnI-R145G, and cTnI-R145G/S23D/S24D protein
systems, based on the three independent MD simulation
runs for each cTnI configuration. In our application of
MM/GBSA, we neglect entropic contributions of the so-
lute to the free energy, which are known to be important
(but difficult to compute) contributors to protein stability
and substrate binding (53). For each simulation,
MM/GBSA analysis was applied to 15 snapshots recorded
at 1 ns intervals. The means for each simulation are re-
ported along with the 95% confidence interval based on
the standard error of the means for each independent
simulation. We find that the mean binding score is more
favorable for the cTnI-R145G systems relative to the
WT. The mean score for the cTnI-R145G/S23D/S24D
case appears to be comparable to that for cTnI-R145G,
but still greater than the WT mean affinity. Thus, these
scores suggest that the contacts formed between the
cTnC/cTnI complex containing cTnI-R145G relative to
the WT are more energetically favorable, whereas the
phosphomimics cTnI-R145G/S23D/S24D contacts are
negligibly different from the nonphosphomimic. Our
findings are in qualitative agreement with experimental
trends that we recently reported, in which the strength
of cTnC/cTnI affinities were ordered as cTnI-R145G >
cTnI-R145G/S23D/S24D > WT, respectively (18). In so
far as stronger C-I binding is correlated with enhanced
Ca2þ affinity, our predictions may in part explain 1), the
left-shifted Ca2þ sensitivity of force generation and pro-
longed initial phase (slow phase) of relaxation for cTnI-
R145G relative to the WT (54); and 2), the insensitivityFIGURE 4 MM/GBSA analysis applied to the cTnC/cTnI interface
(cTnC residues 1–90, cTnI residues 138–171) using 150 snapshots recorded
at 1 ns intervals for WT (green), cTnI-R145G (blue), and cTnI-R145G/
S23D/S24D (red) cTn complexes. Each bar represents the mean from three
independent simulations, and error bars represent the 95% confidence inter-
val. To see this figure in color, go online.
Biophysical Journal 108(2) 395–407of Ca2þ-dependent myosin ATPase activity to PKA phos-
phorylation of cTnI-R145G relative to the WT (12).Calcium coordination
Previous solution biochemical measurements demonstrated
an increased binding affinity of Ca2þ to cTn containing
cTnI-R145G compared with WT cTnI (16). However,
upon PKA phosphorylation, there is a decrease in Ca2þ
binding affinity for cTn containing either cTnI-R145G or
WT (9). Thus, it is reasonable to hypothesize that the
cTnI-R145G mutation and PKA phosphorylation may both
impact Ca2þ binding stability in site II. Due to the nature
of divalent cations, it is very difficult to calculate the bind-
ing affinities of Ca2þ accurately. Therefore, we investigated
one measure related to Ca2þ binding in site II in cTnC: the
time evolution of distances between the bound Ca2þ ion and
its coordinating residues. In the crystal structures, Ca2þ is
coordinated with six atoms in cTnC site II residues: Asp-
65 OD2, Asp-67 OD2, Ser-69 OG, Asp-73 OD2, Glu-76
OE1, and Glu-76 OE2. As observed in previous studies
(17), the coordinating behavior of Asp-65, Asp-67, Asp-
73, and Glu-76 did not change for WT cTn in the absence
or presence of cTnI-S23D/S24D. Data for the cTnI-
R145G and cTnI-R145G/S23D/S24D cTn simulations are
shown in Fig. S3. The most interesting behavior was
observed for Ser-69 OG and, perhaps, Thr-71 OG1. Fig. 5
shows those distances over the course of the three indepen-
dent 150 ns simulations for WT, cTnI-R145G, and
cTnI-R145G/S23D/S24D cTn systems. The coordination
behavior for both residues fluctuated over the course of
the simulations for all three systems, in contrast to the sta-
bility of the other four coordinating residues (Fig. S3).
Thr-71 generally did not coordinate, in agreement with
structural data from x-ray crystallography. The most pro-
nounced difference between the simulations was observed
in coordination of Ser-69. As demonstrated in Fig. 5, Ser-
69 was the most flexible of all the coordinating residues,
which is consistent with previous findings (17,37,55). How-
ever, the percent-in-contact time of Ser-69 varied among the
different systems. Whereas Ser-69 was coordinating for
~10% of the total cumulative simulation time of 450 ns in
the WT system, this fraction increased to 29% in the
cTnI-R145G system, indicating a stronger interaction and
a possible stabilization. This may suggest how the Ca2þ
binding affinity is increased for cTn containing cTnI-
R145G, in agreement with previous studies on cTnC muta-
tions in which Ca2þ binding at site II was stabilized (37).
Interestingly, the contact time was decreased to 6% upon
introduction of the phosphomimic mutation (cTnI-R145G/
S23D/S24D mutant system), in agreement with a reduction
in Ca2þ binding affinity seen in previous solution studies
(18). Together, these experimental and simulation data sug-
gest that Ser-69 may be a critical coordinating position for
conferring the Ca2þ binding affinity of site II in cTn.
FIGURE 5 Distances between Ca2þ and two
coordinating cTnC site II atoms Ser-69 OG (left)
and Thr 71 OG1 (right) over the course of the
MD simulations for the WT (top), the cTnI-
R145G system (center), and the cTnI-R145G/
S23D/S24D mutant system (bottom). Results for
the three independent simulations (simulation 1
(black), simulation 2 (red), and simulation 3
(blue)) are overlaid in the plots. To see this figure
in color, go online.
Troponin HCM Mutation Simulations 401Contact analysis identifies hotspot residue
contact pairs that are most affected by
introduction of the cTnI-R145G and bis-
phosphomimic mutations
In the troponin complex, the C-I interaction is a critical
point in the Ca2þ activation of contraction, and thus it makes
sense to consider this as a point of modulation during b-
adrenergic stimulation. There are three regions of contacts
that are of particular interest: 1), C-I contacts between the
switch and inhibitory peptides and the cTnC molecule; 2),
C-I contacts between the cTnI N-terminal extension and
the cTnC molecule; and 3), intrasubunit cTnI contacts be-
tween the cTnI N-terminal extension and the inhibitory
peptide. In a previous study, we elucidated these contacts
for the WT and cTnI-S23D/S24D cTn systems (17). Here,
we performed a contact analysis of the cTnI-R145G and
cTnI-R145G/S23D/S24D cTn systems.
cTnI switch peptide-NcTnC and cTnI inhibitory peptide-cTnC
interactions
First, we analyzed contacts between the cTnI switch pep-
tide (cTnI residues 148–164) and NcTnC (cTnC residues
1–89), and between the cTnI inhibitory peptide (cTnI resi-
dues 138–147) and cTnC. The results are shown in Fig. S4
(comparison of cTnI-R145G with WT) and Fig. 6 (compar-
ison of cTnI-R145G with cTnI-R145G/S23D/S24D). Addi-
tionally, Fig. S5 shows a similar comparison with respect
to the phosphorylation simulations (comparison of cTnI-
R145G with cTnI-R145G/PS23/PS24). Average contact
maps for interactions between the cTnI switch peptideand NcTnC are shown in panels A (cTnI-R145G model)
and C (WT or the cTnI-R145G/S23D/S24D or cTnI-
R145G/PS23/PS24 model, respectively). The blue end of
the spectrum (value ¼ 0) reflects no contact between a res-
idue-residue pair during the total cumulative simulation
time of 450 ns, and the red end of the spectrum (value ¼
1) represents 100% contact time between a residue-residue
pair. Contact patterns reminiscent of the WT systems,
where cTnC helices A, B, and D interact with the cTnI
switch peptide, are observed. There is no dramatic change
in the contact pattern of the switch peptide residues due
to either introduction of cTnI-R145G or subsequent phos-
phomimic mutations (as well as phosphorylation of S23
and S24), as can be seen in the difference contact map
for panels A and C (Figs. 6 E, S4 E, and S5 E). In this
map, the color green (value ¼ 0) reflects no difference be-
tween the two systems, the red end of the spectrum (values
> 0) reflects more contacts in the cTnI-R145G cTn system,
and the blue of the spectrum (values < 0) indicates more
contacts in the WT or cTnI-R145G/S23D/S24D or cTnI-
R145G/PS23/PS24 model, respectively. The right-hand
side panels in Figs. 6, S4, and S5 (panels B and D) show
the contacts between cTnI inhibitory peptide and cTnC.
The inhibitory peptide interacts with two main regions of
cTnC: the cTnC helix C and the linker between the N-
and C-terminal lobes of cTnC. The difference contact
maps indicate that R145 breaks most of the contacts it
has formed upon mutation to glycine (Fig. S4 F). Fig. 6
F also indicates that more stable interactions between the
inhibitory peptide and its interacting regions are formed
as a consequence of phosphomimic mutations. This isBiophysical Journal 108(2) 395–407
FIGURE 6 (A and C) Average contact maps of residue-residue pairs between NcTnC (cTnC residues 1–89) and cTnI switch peptide (cTnI residues 148–
164) for (A) cTnI-R145G and (C) cTnI-R145G/S23D/S24D complexes. (B and D) Average contact maps of residue-residue pairs between cTnC and cTnI
inhibitory peptide (cTnI residues 138–147) for (B) cTnI-R145G and (D) cTnI-R145G/S23D/S24D complexes. (E) Difference contact map of residue-residue
pairs between NcTnC and cTnI switch peptide that were most affected by introduction of the phosphomimic mutations. (F) Difference contact map of res-
idue-residue pairs between cTnC and cTnI inhibitory peptide that were most affected by introduction of phosphomimic mutations. (E and F) In the difference
contact maps, values > 0 (yellow and red) correspond to two residues that are more frequently in contact in the cTnI-R145G simulation compared with the
cTnI-R145G/S23D/S24D simulation. Values< 0 (blue) correspond to two residues that are more frequently in contact in the cTnI-R145G/S23D/S24D simu-
lation compared with the cTnI-R145G simulation.
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Troponin HCM Mutation Simulations 403indicative of a stabilization of the cTnI inhibitory peptide
upon phosphorylation. This effect is mirrored in the simu-
lations of the real phosphorylations, as can be seen in
Fig. S5 F.
NcTnI-NcTnC interactions
Second, we analyzed contacts between NcTnI (cTnI resi-
dues 1–41) and NcTnC (cTnC residues 1–89). The results
are shown in Fig. S6 (comparison of cTnI-R145G with
WT) and Fig. 7 (comparison of cTnI-R145G with cTnI-
R145G/S23D/S24D). Additionally, Fig. S7 shows a similar
comparison with respect to the phosphorylation simulations
(comparison of cTnI-R145G with cTnI-R145G/PS23/
PS24). Average contact maps are shown in panels A
(cTnI-R145G model) and B (WT or cTnI-R145G/S23D/
S24D or cTnI-R145G/PS23/PS24 model). The blue end
of the spectrum (value ¼ 0) reflects no contact between a
residue-residue pair during the total cumulative simulation
time of 450 ns, and the red end of the spectrum (value ¼ 1)
represents 100% contact time between a residue-residueFIGURE 7 (A and B) Average contact map of residue-residue pairs between N
R145G and (B) cTnI-R145G/S23D/S24D complexes. (C) Difference contact map
by introduction of the phosphomimic mutations. Values > 0 (yellow and red) c
R145G simulation compared with the cTnI-R145G/S23D/S24D simulation. Valu
in the cTnI-R145G/S23D/S24D simulation compared with the cTnI-R145G sim
the last 70 ns (from 80 ns to 150 ns) MD simulations for cTnI-R145G and cTnI-R
the B-helix (residues 38–48) and C-helix (residues 54–64) are in blue, and NcTpair. Most of the interactions involved two cTnC regions:
the loop between helices A and B (site I) and the site II
Ca2þ binding site. The introduction of cTnI-R145G
changed the general contact pattern and maintained con-
tacts with site I and site II (see Fig. S6). Interestingly, all
interaction hotspots also remained after introduction of
either the S23D/S24D mutations (see Fig. 7) or the PS23/
PS24 phosphorylations (see Fig. S7). This is in contrast
to the behavior observed for the WT system (17), where
contacts between NcTnI and the loop between cTnC heli-
ces A and B were completely lost upon introduction of
the phosphomimic mutations. Loss of contacts was associ-
ated with a large-scale repositioning of the NcTnI peptide
to form stable interactions with the cTnI inhibitory peptide,
which we hypothesized to be a crucial molecular conse-
quence of phosphorylation (17). To our knowledge, this
is the first indication that cTnI-R145G alters the behavior
of cTn upon phosphorylation. Again, this effect was
observed in both the phosphomimic and phosphorylated
systems.cTnC (cTnC residues 1–89) and NcTnI (cTnI residues 1–41) for (A) cTnI-
of residue-residue pairs between NcTnC and NcTnI that were most affected
orrespond to two residues that are more frequently in contact in the cTnI-
es< 0 (blue) correspond to two residues that are more frequently in contact
ulation. (D) Comparison of interactions between NcTnC and NcTnI during
145G/S23D/S24D complexes. The NcTnC (residues 1–89) is shown in gray,
nI (residues 1–41) is in red.
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It was previously shown both experimentally and computa-
tionally that bisphosphorylation at S23/S24 of the N-termi-
nal residues in cTnI or mutation of these positions to Asp
results in a weakened interaction with NcTnC residues
(56,57). It was also shown that the cTnI N-terminal resi-
dues are repositioned to form favorable interactions with
basic regions of cTnI, such as the inhibitory region of
cTnI (17,56). This constitutes an important mechanism
by which PKA can regulate cTn structure and dynamics.
An interesting question arises: to what degree does the
HCM mutation cTnI-R145G impact this mechanism? We
hypothesized that cTnI-R145G dramatically disrupts this
mechanism to blunt the ability of PKA regulation. To
investigate this, we elucidated intrasubunit contacts be-
tween NcTnI (cTnI residues 1–41) and the cTnI inhibitory
peptide (cTnI residues 138–147). Fig. 8 shows the corre-
sponding contact plots for (A) WT, (B) cTnI-R145G, (C)
cTnI-S23D/S24D, (D) cTnI-R145G/S23D/S24D, and (E)
cTnI-R145G/PS23/PS24 cTn complexes. As was previ-
ously observed (17), there were no interactions between
the cTnI inhibitory peptide and NcTnI in the WT cTn
system (Fig. 8 A). However, this changed dramatically
upon introduction of the cTnI-S23D/S24D mutations
(Fig. 8 C): all three independent runs formed contacts be-
tween cTnI residues 9–14 and 140–142 for ~50% of the
simulation time (Fig. 8 C). No intrasubunit interactions
were seen in the cTnI-R145G system (Fig. 8 B), which is
not surprising since no phosphomimic mutations or phos-
phorylations were present. However, introduction of the
cTnI-R145G mutation also blunted all NcTnI-cTnI inhibi-
tory peptide interactions in the phosphomimic system
(cTnI-R145G/S23D/S24D; Fig. 8 D) as well as the phos-
phorylated system (cTnI-R145G/PS23/PS24; Fig. 8 E).
Introduction of the glycine in the cTnI R145 inhibitory
peptide residue may change the structural dynamics of
the cTnI inhibitory peptide in a way that interferes with
its interaction with NcTnI. This suggests that a possible
mechanism of action of the cTnI-R145G mutation is inter-
ference with PKA regulation. We speculate that the intra-
cTnI contacts increase the stability of the inhibitory/switch
peptide region with NcTnC, which may explain the
increased C-I affinity in the presence of the cTnI-R145G
mutation (18). PKA phosphorylation speeds the early phase
of relaxation, possibly resulting from the altered NcTnI-
cTnI inhibitory peptide interactions in the presence of the
cTnI-R145G mutation.CONCLUSIONS
Computational methods can play an important role in
elucidating the molecular underpinnings of mutational ef-
fects on protein structure, dynamics, and function. Here,
we used MD simulations to investigate the effects of a mu-Biophysical Journal 108(2) 395–407tation of the inhibitory subunit of human cTn. cTnI-R145G
is associated with HCM, a vicious genetic heart muscle dis-
ease that causes sudden death in otherwise healthy young
adults. Additionally, we investigated the combined effects
of cTnI-R145G and phosphorylation by PKA during b-
adrenergic stimulation through both cTnI-R145G/S23D/
S24D phosphomimics and cTnI-R145G/PS23/PS24 phos-
phorylations. In summary, we found that cTnI-R145G
stabilized crucial Ca2þ-coordinating interactions without
changing the overall cTn dynamics. On the other hand,
cTnI-R145G/S23D/S24D destabilized Ca2þ coordination
and increased overall cTn fluctuations. Most notably,
cTnI-R145G also altered the intrasubunit cTnI inhibitory
peptide interaction with NcTnI in a way that blunted the
ability of PKA phosphorylation to cause a repositioning
of the N-terminal extension. These results suggest a struc-
tural basis for the blunting of PKA effects on the C-I inter-
action by cTnI-R145G. Furthermore, we performed a
vigorous comparison of effects caused by phosphomimic
mutations versus phosphorylated serines. All of the results
presented here were independent of the system used, which
suggests that phosphomimic mutations are a valuable sub-
stitute at least for simulations of phosphorylated cTn.
Although it is interesting in its own right, this study is
the third in a series of computational/experimental studies
that have been able to show that the C-I interaction plays a
crucial role in modulating the effects of phosphorylation
and mutation.
We previously showed that with WT cTn, cTnI-S23D/
S24D phosphomimic mutations result in a reduction of C-
I interactions and accelerate the early phase of relaxation
in cardiac myofibrils (17). MD simulations showed that
the cTnI-S23D/S24D mutations resulted in the formation
of new intrasubunit contacts between the N-terminal exten-
sion and the inhibitory peptide of cTnI. We concluded from
this that this new interaction could destabilize the cTnI
switch peptide interaction with cTnC, resulting in the
decreased C-I interaction and faster relaxation. Here, we
demonstrate that this interaction does not occur when cTn
contains cTnI-R145G. Thus, it may be that changes in the
C-I interaction and early-phase relaxation with phosphory-
lation are blunted in the presence of the mutation, which
may impair the early phase of diastole in hearts with this
HCM-associated mutation.SUPPORTING MATERIAL
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FIGURE 8 (A–E) Average contact map of residue-residue pairs between cTnI inhibitory peptide (cTnI residues 138–147) and NcTnI (cTnI
residues 1–41) for (A) WT, (B) cTnI-R145G, (C) cTnI-S23D/S24D, (D) cTnI-R145G/S23D/S24D, and (E) cTnI-R145G/PS23/PS24 cTn
complexes.
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